About SK biopharmaceuticals
SK biopharmaceuticals is a company based in Seongnam-si (South Korea) founded in 1993.. The company has 265 employees as of December 31, 2024. SK biopharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Kriya Therapeutics and PureTech Health, among others.
- Headquarter Seongnam-si, South Korea
- Employees 265 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sk Biopharmaceuticals Co., Ltd.
-
Annual Revenue
$371.31 M (USD)54.3as on Dec 31, 2024
-
Net Profit
$163.24 M (USD)832.18as on Dec 31, 2024
-
EBITDA
$77.12 M (USD)599.25as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
265
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SK biopharmaceuticals
SK biopharmaceuticals is a publicly listed company on the KRX with ticker symbol 326030 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of SK biopharmaceuticals
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2012 | Amount | Unspecified - SK biopharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SK biopharmaceuticals
SK biopharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include KDDF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specializes in R&D for manufacturing therapeutic drugs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SK biopharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SK biopharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sk Biopharmaceuticals Comparisons
Competitors of SK biopharmaceuticals
SK biopharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Kriya Therapeutics and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sk Biopharmaceuticals
Frequently Asked Questions about SK biopharmaceuticals
When was SK biopharmaceuticals founded?
SK biopharmaceuticals was founded in 1993 and raised its 1st funding round 19 years after it was founded.
Where is SK biopharmaceuticals located?
SK biopharmaceuticals is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Who is the current CEO of SK biopharmaceuticals?
Jeong Woo Cho is the current CEO of SK biopharmaceuticals.
How many employees does SK biopharmaceuticals have?
As of Dec 31, 2024, the latest employee count at SK biopharmaceuticals is 265.
What is the annual revenue of SK biopharmaceuticals?
Annual revenue of SK biopharmaceuticals is $371.31M as on Dec 31, 2024.
What does SK biopharmaceuticals do?
Founded in 1993, SK biopharmaceuticals is based in Seongnam-si, South Korea, and operates in the pharmaceutical sector. Focus is placed on developing drugs for central nervous system disorders and anticancer applications. Key products include cenobamate for epilepsy, carisbamate for Lennox-Gastaut syndrome, and relenopride for rare neurological disorders. Operations emphasize research and therapeutic innovation in these fields.
Who are the top competitors of SK biopharmaceuticals?
SK biopharmaceuticals's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.
Is SK biopharmaceuticals publicly traded?
Yes, SK biopharmaceuticals is publicly traded on KRX under the ticker symbol 326030.
Who are SK biopharmaceuticals's investors?
SK biopharmaceuticals has 1 investor. Key investors include KDDF.
What is SK biopharmaceuticals's ticker symbol?
The ticker symbol of SK biopharmaceuticals is 326030 on KRX.